Journal: PLOS ONE
Article Title: Rosiglitazone alleviates LPS-induced endometritis via suppression of TLR4-mediated NF-κB activation
doi: 10.1371/journal.pone.0280372
Figure Lengend Snippet: The protein levels of TLR4, p-p65 and p-IκBα in HESCs were measured by Western blotting. GAPDH served as the control. Control is the control group; LPS is the LPS group; TAK-242 was the 1 μM/L TAK-242 treatment groups per cell plate, RGZ was the 10 μM/L RGZ treatment groups per cell plate, LPS+RGZ was the 30min incubation of the cell pretreatment with 10 μM RGZ followed by LPS induced for 24 h incubation, LPS+RGZ+TAK-242 was the 2 h incubation of 1 μM TAK-242 combined with 30min incubation of with 10 μM RGZ followed by LPS induced for 24 h incubation. Data represent the mean ± SEM. ## P < 0.01, * P < 0.05 and ** P < 0.01 compared with control group and LPS group, respectively.
Article Snippet: Rosiglitazone (BRL-49653) and a TLR4 signaling inhibitor TAK-242 (CLI-095) were purchased from MedChemExpress (NJ, USA) and dissolved in dimethyl sulfoxide (DMSO).
Techniques: Western Blot, Control, Incubation